NCT04393233View on ClinicalTrials.gov

Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

August 23, 2020

Study Completion Date

August 23, 2020

Conditions
Rheumatoid ArthritisCOVID
Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT04393233 - Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation | Biotech Hunter | Biotech Hunter